.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Identify first generic entrants
  • Set up watchlists for daily email updates

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Fuji
Chubb
Daiichi Sankyo
Cantor Fitzgerald
AstraZeneca
Baxter
Mallinckrodt
McKinsey
US Army
Accenture

Generated: July 20, 2017

DrugPatentWatch Database Preview

NUPRIN Drug Profile

« Back to Dashboard

What is the patent landscape for Nuprin, and when can generic versions of Nuprin launch?

Nuprin is a drug marketed by J And J Consumer Inc and Bristol Myers and is included in three NDAs.

The generic ingredient in NUPRIN is ibuprofen. There are sixty-four drug master file entries for this compound. Two hundred and fifty-five suppliers are listed for this compound. Additional details are available on the ibuprofen profile page.

Summary for Tradename: NUPRIN

Patents:0
Applicants:2
NDAs:3
Suppliers / Packagers: see list4
Bulk Api Vendors: see list109
Clinical Trials: see list3
Patent Applications: see list9,377
Formulation / Manufacturing:see details
Drug Prices:see details
DailyMed Link:NUPRIN at DailyMed
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
J And J Consumer Inc
NUPRIN
ibuprofen
TABLET;ORAL019012-001May 18, 1984DISCNNoNo► Subscribe► Subscribe
Bristol Myers
NUPRIN
ibuprofen
TABLET;ORAL072036-001Feb 16, 1988DISCNNoNo► Subscribe► Subscribe
J And J Consumer Inc
NUPRIN
ibuprofen
TABLET;ORAL019012-002Jul 29, 1987DISCNNoNo► Subscribe► Subscribe
Bristol Myers
NUPRIN
ibuprofen
TABLET;ORAL072035-001Feb 16, 1988DISCNNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Argus Health
Fish and Richardson
Harvard Business School
Chinese Patent Office
US Army
Novartis
Federal Trade Commission
Dow
Medtronic
Deloitte

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot